M Brozović, Y Stirling, L Klenerman, L Lowe. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » AgedDose-Response Relationship, DrugFemaleHeparin/administration & dosageHeparin/bloodHeparin/therapeutic useHumansInjections, SubcutaneousMaleMiddle AgedPostoperative Complications/prevention & controlThromboembolism/prevention & controlTime Factors
Substances: See more » Heparin
Year: 1974 PMID: 4137004 DOI: 10.1016/s0140-6736(74)91654-7
Source DB: PubMed Journal: Lancet ISSN: 0140-6736 Impact factor: 79.321